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GastritisBackground: Infection with Helicobacter pylori (H. pylori) causes persistent gastritis that may progress to
fatal gastric cancer. The cytotoxin-associated gene A protein (CagA), encoded by the cytotoxin-associated
gene A (cagA) is the main virulence factor associated with more severe clinical outcomes. It is further
divided into Western-type CagA and East Asian-type CagA. The East Asian-type CagA induces more
cytoskeleton changes and is more likely to be associated with gastric cancer.
Aim of the study: In the current study we aimed to identify the most prevalent H. pylori cagA genotype
among Egyptian patients suffering from dyspepsia and to examine its possible correlation with the asso-
ciated clinical condition.
Patients and methods: Four biopsies were obtained from the antrum and angularis from each of 113 adult
patients, who underwent upper endoscopy at the Endoscopy Unit, Theodor Bilharz Research Institute
(TBRI) Hospital for the analysis of H. pylori by rapid urease test and detection of 16S rRNA. Nested PCR
assay was used to determine cagA genotype.
Results: Sixty (53.1%) dyspeptic patients were found infected with H. pylori. Although Egypt has a high
prevalence of H. pylori infection, low prevalence of cagA was detected (26.5%). Western type cagA is
the predominant type (62.5%) while East Asian type was not detected and others (37.5%) remain unchar-
acterized. Western-genotype cagA genotype was found in 80% of patients with peptic ulcer disease and
40% of patients with gastritis.
Conclusion: Absence of the more virulent East Asian cagA genotype, which is the strongest risk factor for
gastric carcinogenesis, may explain the very low gastric cancer rate among Egyptian population com-
pared to other parts of the world. This finding demands further molecular studies using whole genome
sequencing and more samples to determine the exact uncharacterized cagA genotype to identify the
actual risk in developing gastroduodenal diseases in Egypt.
 2018 Ain Shams University. Production and hosting by Elsevier B.V. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Helicobacter pylori has been classified as a class I carcinogen by
the International Agency for Research on Cancer. Infection with
this pathogen causes persistent gastritis and is directly linked to
the development of gastric cancer which is the fourth most
common cancer and the second leading cause of cancer deaths
worldwide [1,2]. Many virulence factors are involved in thepathogenicity of H. pylori including; urease, vacuolating cytotoxin
(a product of the vacA gene) and the immunogenic cytotoxin-
associated gene A protein (CagA), encoded by the cytotoxin-
associated gene A (cagA). While the vacA gene is present in all
strains of H. pylori, cagA is not. The cagA is a virulence gene located
in the cagA pathogenicity island (cag PAI) of the bacterial genome
and is frequently associated with more severe clinical outcomes.
The cagA encodes proteins that increase the virulence potencies
of strains; by increasing host-cell cytokine production and altering
protein tyrosine phosphorylation [3].
The CagA protein is further divided into Western-type CagA and
East Asian-type CagA, by the repeat sequence Glu-Pro-Ile-Tyr-Ala
(EPIYA) motifs at its N terminus [4]. Four different CagA EPIYA
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defined based on the amino acid sequences surrounding the EPIYA
residue. CagA proteins nearly always possess an EPIYA-A and an
EPIYA-B, followed by various numbers of EPIYA-C repeats in
Western-type or EPIYA-D motifs in East Asian type strains. It has
been suggested that the considerable variation in number of
repeating EPIYA-C or -D motifs determines the biological activity
of CagA. When CagA is injected from the bacteria into gastric
epithelial cells, it undergoes tyrosine phosphorylation and binds
to Src homology 2 domain-containing protein-tyrosine phos-
phatase (SHP-2). SHP-2 is known to play an important positive role
in mitogenic signal transduction. In addition, SHP-2 is actively
involved in the regulation of spreading, migration and adhesion
of cells. So, the deregulation of SHP-2 by translocated CagA may
induce abnormal proliferation and movement of gastric epithelial
cells [5]. The affinity of the East Asian-type CagA to SHP-2 is signif-
icantly higher than that of the Western-type CagA. Thus, East
Asian-type CagA induces more cytoskeleton changes and is more
likely to be associated with gastric cancer [4].
Therefore, extensive genotyping of the cagA gene has been car-
ried out in many countries using H. pylori strains isolated from
patients with gastric diseases [3,6,7].
Since the East Asian CagA H. pylori strains are associated with
higher gastric pathogenicity, we aimed to identify the most preva-
lent H. pylori cagA genotype among Egyptian patients suffering
from dyspepsia and to examine its possible correlation with asso-
ciated clinical condition. To the best of our knowledge this is the
first study from Egypt that investigates cagA genotyping and its
possible outcome clinically.
2. Subjects and methods
2.1. Patients and specimens
A total number of 113 adult patients, who underwent upper
endoscopy with various dyspepsia symptoms (abdominal or epi-
gastric pain, vomiting and/or heartburn) at the Endoscopy Unit,
Theodor Bilharz Research Institute (TBRI) Hospital from March
2013 to February 2016, were enrolled in this cross-sectional study.
None of them received non-steroidal anti-inflammatory drugs,
antibiotics, H2 receptors antagonists or proton pump inhibitors
in the past four weeks prior to the study. Thorough endoscopic
examination of the oesophagus, stomach and duodenum was done
together, as well as clinical assessment of the patient condition
(gastritis, peptic ulceration, normal endoscopy and other findings).
From each patient, four biopsies were obtained from the antrum
and angularis in 2 tubes. One tube was tested for rapid urease test
(Bussero, Milan, Italy) and the other tube was stored in sterile
physiological saline in sterile Eppendorf tubes and kept at 70 C
in sterile physiological saline until processed as panel for DNA
extraction and PCR assays. The protocol was approved by TBRITable 1
Oligonucleotide primers used for PCR analysis.
Target Genes Primer Primer Sequence
16S rRNA F
R
50-CTG GAG AGA CTA A
50-ATT ACT GAC GCT G
cagA F1
F2
50-GGA ACC CTA GTC A
50-CCA ATA ACA ATA A
R1
R2
50-GCT TTA GCT TCT G
50-AAT TCT TGT TCC CT
cagA-Western F
R
50-AGG CAT GAT AAA G
50-AAA GGT CCG CCG A
cagA-East-Asian F
R
50-AAA GGA GTG GGC
50-CCT GCT TGA TTT Ginstitutional review board (FWA00010609) and all patients pro-
vided a written informed consent.
2.2. DNA extraction from gastric biopsy specimens
Genomic DNA was extracted from gastric biopsy specimens
using (QIAamp DNA Mini Kit (50) 51304 from QIAGEN, USA), cata-
logue number #51304 following manufacturer guidelines.
2.3. PCR analysis
The PCR analysis for 16S rRNA was done to confirm presence of
H. pylori according to Chisholm et al. (2001) [8]. To detect cagA
genotype, nested PCR assay was performed as described by Hirai
et al. (2009) [9,10], using genotype-specific primers and two
rounds of PCR. The first round was performed using a common for-
ward primer (F1) and either of the two reverse primers (R1 or R2)
(Table 1). The PCR cycling conditions for the first round were as fol-
lows: 95 C for 10 min, then 40 cycles at 94 C for 15 s, 55 C for 30
s and 68 C for 30 s. The second round was performed using 10 ml of
the PCR products obtained in the first round as the template. In the
second round, primers specific to these two types were used in
separate reactions. The cycling conditions of the second round of
PCR were as follows: 94 C for 2 min, then 30 cycles at 98 C for
10 s and 63 C for 30 s. PCR amplifications were carried out Bio
Rad T100 thermal cycler, USA. Each PCR product was separated
on 2% agarose gel with ethidium bromide and 100 bp ladder used
as DNA molecular weight standard.
2.4. Statistical analysis
Results are expressed as number (%). Comparison between cat-
egorial data [number (percent)] was performed Chi square test.
Statistical Package for Social Sciences (SPSS) computer program
(version 19 windows) was used for data analysis. P value 0.05
was considered significant.
3. Results
Sixty (60) out of 113 (53.1%) dyspeptic patients were found
infected with H. pylori by positive rapid urease test and confirmed
by 16S rRNA PCR. Among the studied 60 H. pylori infected patients,
40 (66.7%) patients were males and 20 (33.3%) were females.
Ages of the patients ranged between 17 and 76 years (49.93 ±
14.28 years). Eighty-five percent (85%) (51/60) of the patients were
from urban regions while 15% (9/60) were from rural areas. Half of
the H. pylori infected patients (31/60, 51.7%) were above 51 years,
46.7% (28/60) were between 21 and 50 years, while only one
patient (1.7%) was below 20 years.
Upper gastrointestinal endoscopy revealed gastritis in 27(45%)




GT AAT GGG TT-30
TA ATG GAC TCAA-30
550 bp [910]
AT ACC GCT TGA-30
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esophageal varices, esophagitis and hiatus hernia were detected in
23 (38.3%).
The PCR analysis revealed cagA gene in 16 (26.6%) of the 60 H.
pylori strains (Fig. 1). The cagA gene was associated with 5/10
(50.5%) and 5/27 (18.5%) of H. pylori strains obtained from PUD
and gastritis cases respectively. Whereas 6/16 of cagA positive
strains were associated with other endoscopic findings. The cagA
Western-genotype was detected in 10/16 (62.5%) of cagA positive
H. pylori strains (Fig. 2). Upon upper endoscopy, cagA Western-
genotype was found in 80% of patients with PUD and 40% of
patients with gastritis. However, the existence of Western cagA
genotype was not significantly associated with a certain endo-
scopic finding (p = 0.411). The cagA East-Asian genotype was not
detected in any of the tested strains and six of the cagA positive
strains were unclassified (Table 2).Fig. 1. Agarose gel 2% for electrophoresis of PCR products of H. pylori cagA. Lane M:
Molecular weight marker (100 bp). Lane 1–3, 7: Negative DNA samples, Lanes 4–6:
Positive strains. The arrow points to expected amplicon band size (550 bp).
Fig. 2. Agarose gel 2% for electrophoresis of PCR products of H. pylori cagA
genotyping. Lane M: Molecular weight marker (100 bp). Lane 2–7, 9: Positive
Western cagA genotype, Lanes 8 &10: Negative DNA samples (unclassified strains).
The arrow points to expected amplicon band size (92 bp).
Table 2
Association between cagA genotypes and endoscopic findings among 60 H. pylori infected

















Data are expressed as N (%).
a PUD: Peptic ulcer disease.
b Others include endoscopic findings other than gastritis and ulcer diseases; oesophag4. Discussion
The study of H. pylori virulence factors in populations is impor-
tant, as they contribute to disease risk. Pathogenesis and disease
outcomes are mediated by a complex interplay between bacterial
virulence factors, host response and environmental factors. The
major pathological feature ofH. pylori infection is due to the activity
of CagA protein encoded by cag PAIwhich is responsible for the syn-
thesis of a type IV secretion system that injects the cagAoncoprotein
into host cells. Therefore, the virulence of H. pylori isolates has been
measured by their ability to produce CagA which plays a major role
in determining the clinical outcome of Helicobacter infections [11].
H. pylori cagA positive strains are considered to be more virulent
causing higher levels of gastric mucosal inflammation in gastritis
and gastric cancer [12,13]. There is increasing evidence that genetic
variability of H. pylori may have clinical importance [14]. H. pylori
has a global distribution and several reports have evidenced geo-
graphical differences in the prevalence of cagA status [15]. The rate
differs from very high in East Asian countries (Japan and part of
China) to low in Western countries (Europe, Middle East, North
Africa, South East Asia) [6,16]. CagA prevalence in Middle East
ranges between 26 and 76%, in Europe ranges between 66 and
73%, in America it ranges between 57 and 75% and in East Asia
ranges between 90 and 100%. Previous studies reported that the
cagA-positive strains are directly associated with acute gastritis,
gastric ulcer, and development of gastric cancer [13,17,18].
In the current study, out of 60 16S rRNA PCR positive H. pylori
infected patients, 26.6% were cagA positive. Compared to previous
Egyptian studies, our result was lower than El-Khlousy et al., 2016
who reported 17 positive cagA H. pylori strains in gastric biopsies
taken from 37 patients who were scheduled for diagnostic endo-
scopy in the gastroenterology unit of Cairo University hospital
(45.9%), however no statistically significant relation was found
between cagA and the degree of gastritis [11]. Our study was com-
parable to another Egyptian one by Abd El Azeem et al. 2017 who
isolated 23 H. pylori isolates from stool samples from 60 dyspeptic
patients in which cagA was positive in 8 strains (8/23; 34.7%) [13].
Regarding other parts of the world, our figure was comparable to
former studies from Jordan (26.4%) and Lebanon (37.5%) [19,20].
Still, it was also lower than previous studies from South and East
Asian countries (more than 90%) [21,22], Iran (70%) [16], Moreover,
wide variation in the prevalence of H. pylori infection has been
reported globally; Africa has the highest pooled prevalence of H.
pylori infection (70.1%), it was 87.7% in Nigeria, whereas
Switzerland had the lowest prevalence (18.9%) [1]. This discrep-
ancy is reflected on the prevalence rate of cagA positive H. pylori
strains and could be related to the difference in studiedpatients.
cagA genotypes
cagA-negative Western Unclassified
5(50.0) 4/5 (80.0) 1/5 (20.0)
22(81.5) 2/5(40.0) 3/5 (60.0)
4(10 0) 0 (0.0) 0 (0.0)
13(68.4) 4/6 (67.0) 2/6 (33.0)
44(73.3) 10/16 (62.5) 6/16 (37.5)
eal varices, gastro-oesophageal reflux, gastric prolapse, hiatus hernia.
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ferent geopgraphical areas [6].
It was reported that H. pylori strains possessing cagA gene
induce more inflammation, ulceration and oncogenesis when com-
pared with cagA-negative strains [23]. In agreement with the find-
ings presented in previous studies [6,23], we observed an
association between cagA-positve status and PUD. A former study
reported that the prevalence of cagA in Egypt was related to the
clinical presentation of H. pylori infection being lowest in asymp-
tomatic controls (11.1%) and increasingly prevalent in non-ulcer
dyspepsia (40%), peptic ulcer (66.7%) and gastric cancer (89%)
[24]. Analysis of the studied cagA gene showed that the Western-
type cagA genotype was the most prevalent as it is detected in
62.5% of cagA positive H. pylori strains. Among the studied H. pylori
infected patients, 80% of patients with PUD and 40% of patients
with gastritis were of cagAWestern-genotype. Six strains remained
uncharacterized. Whereas the East Asian type cagA could not be
detected in any of the tested strains. In this regard, same finding
was reported in Iran [6] where Western type cagA EPIYA-C motif
was found in all cagA positive H. pylori strains using PCR followed
by sequencing but there was no East Asian cagA EPIYA-D motif. In
contrast, the East Asian type cagA is the dominant type in Korea
[25]. Whereas in Malaysia and Thailand both types of cagA
(Western and East Asian) are present [26,27].
There are large sequence differences that distinguish the cagA
gene fragments in the Western from the East Asian strains. The
grades of inflammation, activity of gastritis and atrophy are signif-
icantly higher in patients with gastritis infected by the East Asian
cagA-positive H. pylori strains where the prevalence of gastric can-
cer is much higher than in patients with gastritis infected by the
cagA-negative or Western cagA-positive strains [5,6]. Since the East
Asian CagA-positive H. pylori is the strongest risk factor for gastric
carcinogenesis [28], the absence of this genotype may explain the
very low gastric cancer rate in Egypt compared to other parts of the
world [29].
5. Conclusion
Although Egypt has a high prevalence of H. pylori infection, low
prevalence of cagA was detected and it has not been significantly
associated with PUD compared to other endoscopic findings. Wes-
tern type cagA is the predominant type while East Asian type was
not detected and others remain uncharacterized. The absence of
the East Asian genotype may explain the very low gastric cancer
rate in Egypt compared to other parts of the world. However, this
finding demands further studies with more specimens and molec-
ular characterization using whole genome sequencing of the H.
pylori genome to determine the exact uncharacterized cagA geno-
type to identify the actual risk in developing gastroduodenal dis-
eases in Egypt.
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